New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Tenax Therapeutics, Inc.
TENX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

24M

Biotechnology

Next Earning date - 12 Aug 2025

24M

Biotechnology

Next Earning date - 12 Aug 2025

5.79USD

Shape0.12 ( 2.12%)
Market Closed (as of Jun 20, 20:00 EDT)
favorite-chart

Relative Strenght

83
favorite-chart

Volume Buzz

893%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

27%

Quote Panel

Shape
Updated June 21, 2025
1W -5.24 % 1M -5.85 % 3M -6.61 % 1Y 91.72 %

Key Metrics

Shape
  • Market Cap

    24.02M


  • Shares Outstanding

    4.15M


  • Share in Float

    3.63M


  • Dividende

    0


  • Earning Date

    12 Aug 2025


  • Price Target

    5.79


  • Average Volume

    17545


  • Beta

    1.622


  • Range

    2.77-7.89


  • Industry

    Biotechnology


  • Website

    https://www.tenaxthera.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

TENX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4M

ShapeNaN%

2026-Revenue

$2.33

Shape-731%

2026-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

15.00(159.07%)

Number of analyst

1

Last analyst upgrade/downgrade

Leerink Partners

initialise

Previous: Not converted

2024-10-24

Now: Outperform

Guggenheim

initialise

Previous: Not converted

2024-10-14

Now: Buy

William Blair

initialise

Previous: Not converted

2024-09-30

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

N/A

-4.00
vs -176.00

Q3.23

arrow
arrow

N/A

-6.40
vs -176.00

Q4.23

arrow
arrow

N/A

-12.98
vs -1.73

Q1.24

arrow
arrow

N/A

-3.12
vs -12.00

Q2.24

arrow
arrow

N/A

-1.83
vs -4.00

Q3.24

arrow
arrow

N/A

-0.19
vs -6.40

Q4.24

arrow
arrow

N/A

-0.18
vs -12.98

Q1.25

arrow
arrow

N/A

-0.28
vs -3.12

Q2.25

arrow
arrow

N/A

-0.24
vs -1.83

Q3.25

arrow
arrow

N/A

-0.26
vs -0.19

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

5.8K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

-100%

NA  vs 5.8K

Q1.25

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

-8%

-0.08
vs -0.10

Q3.23

arrow
arrow

-17%

-0.17
vs -0.08

Q4.23

arrow
arrow

-40%

-0.40
vs -0.17

Q1.24

arrow
arrow

-31%

-0.31
vs -0.40

Q2.24

arrow
arrow

-40%

-0.40
vs -0.31

Q3.24

arrow
arrow

-4%

-0.04
vs -0.40

Q4.24

arrow
arrow

-7%

-0.07
vs -0.04

Q1.25

arrow
arrow

-10%

-0.10
vs -0.07

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

15

15
vs 15

NA

Q3.22

arrow
arrow

20

20
vs 15

33%

Q4.22

arrow
arrow

15

15
vs 20

-25%

Q1.24

arrow
arrow

9

9
vs NA

NA

Q2.24

arrow
arrow

10

10
vs 9

11%

Q3.24

arrow
arrow

19

19
vs 10

90%

Q4.24

arrow
arrow

21

21
vs 19

11%

Q1.25

arrow
arrow

23

23
vs 21

10%

Earnings Growth

Latest News